GRN Gene Ceroid lipofuscinosis neuronal type 11 Genetic Test
At DNA Labs UAE, we offer the GRN Gene Ceroid lipofuscinosis neuronal type 11 Genetic Test at a cost of AED 4400.0.
Test Components
- Price: 4400.0 AED
- Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
- Report Delivery: 3 to 4 Weeks
- Method: NGS Technology
- Test Type: Metabolic Disorders
- Doctor: General Physician
- Test Department: Genetics
Pre Test Information
Prior to undergoing the GRN Gene Ceroid lipofuscinosis neuronal type 11 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session will be conducted to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 11.
Test Details
The GRN gene, also known as progranulin gene, is associated with a neurodegenerative disorder called neuronal ceroid lipofuscinosis type 11 (NCL11). This disorder is characterized by the accumulation of lipofuscin, a fatty pigment, in neurons throughout the body.
NCL11 typically presents in early adulthood with symptoms such as progressive cognitive decline, behavioral changes, seizures, and movement disorders.
NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of NCL11, NGS genetic testing can be performed to identify mutations or variants in the GRN gene.
This test can help confirm a diagnosis of NCL11 and provide important information for genetic counseling and family planning.
NGS genetic testing involves sequencing the DNA of an individual to identify any genetic changes in the GRN gene. The test can detect small mutations, deletions, insertions, or other genetic alterations that may be responsible for NCL11.
By analyzing the entire coding region of the GRN gene, NGS testing provides comprehensive coverage and higher accuracy compared to traditional sequencing methods.
It’s important to note that NGS genetic testing is typically recommended for individuals who have symptoms consistent with NCL11 or a family history of the condition. A healthcare professional, such as a genetic counselor or neurologist, can guide patients and their families through the testing process and help interpret the results.
Test Name | GRN Gene Ceroid lipofuscinosis neuronal type 11 Genetic Test |
---|---|
Components | |
Price | 4400.0 AED |
Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
Report Delivery | 3 to 4 Weeks |
Method | NGS Technology |
Test type | Metabolic Disorders |
Doctor | General Physician |
Test Department: | Genetics |
Pre Test Information | Clinical History of Patient who is going for GRN Gene Ceroid lipofuscinosis neuronal type 11 NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Ceroid lipofuscinosis neuronal type 11 |
Test Details |
The GRN gene, also known as progranulin gene, is associated with a neurodegenerative disorder called neuronal ceroid lipofuscinosis type 11 (NCL11). This disorder is characterized by the accumulation of lipofuscin, a fatty pigment, in neurons throughout the body. NCL11 typically presents in early adulthood with symptoms such as progressive cognitive decline, behavioral changes, seizures, and movement disorders. NGS (Next-Generation Sequencing) genetic testing is a technique used to analyze multiple genes simultaneously. In the context of NCL11, NGS genetic testing can be performed to identify mutations or variants in the GRN gene. This test can help confirm a diagnosis of NCL11 and provide important information for genetic counseling and family planning. NGS genetic testing involves sequencing the DNA of an individual to identify any genetic changes in the GRN gene. The test can detect small mutations, deletions, insertions, or other genetic alterations that may be responsible for NCL11. By analyzing the entire coding region of the GRN gene, NGS testing provides comprehensive coverage and higher accuracy compared to traditional sequencing methods. It’s important to note that NGS genetic testing is typically recommended for individuals who have symptoms consistent with NCL11 or a family history of the condition. A healthcare professional, such as a genetic counselor or neurologist, can guide patients and their families through the testing process and help interpret the results. |